91青青草视频,青草成人精品免费,红桃视频网站在线观看

Tsinghua Develops Long-Lived CAR-T Cells for Single-Dose Obesity & Diabetes Therapy Semaglutide Tsinghua University develops long-lived CAR-T cells that enable single-dose, long-term treatment of obesity and diabetes, offering a potential one-time therapy for chronic diseases.
Henlius Biotech H1 2025 Financial Report Henlius Biotech Henlius reports H1 2025 results: overseas profits soar 200%, global product expansion, and innovation pipeline growth, driving ‘Globalization 2.0’ and next-gen therapies worldwide.
Adaptimmune Sells Four Core Cell Therapies Adaptimmune Adaptimmune Therapeutics sells four core cell therapies to US WorldMeds for $85M, ensuring continued patient access and advancing development of TECELRA, Lete-Cel, Afami-Cel, and Uza-Cel.
CD19 Targeted Drugs: A "Lifeline" for Lymphoma Patients? Biotech Explore how CD19-targeted CAR-T and CAR-NK cell therapies are transforming treatment for relapsed/refractory B-cell lymphoma. Learn about their mechanisms, clinical outcomes, safety profiles, and future potential in cancer care.
Stem Cell Therapy: 5 Major Challenges Biotech Explore the five major challenges in stem cell therapy, including sourcing, immune response, functional heterogeneity, post-transplant viability, and targeted delivery. Learn how these affect clinical outcomes.
BioNTech Acquires CureVac in $1.25B mRNA Deal BioNTech BioNTech acquires CureVac in a $1.25 billion all-stock deal, expanding its mRNA cancer therapy pipeline and resolving ongoing litigation. The acquisition strengthens BioNTech’s oncology strategy and manufacturing capabilities.
Bristol Myers Squibb Bets on ACP3 in $1.35B Deal BMS Bristol Myers Squibb teams up with Philochem in a $1.35B radiopharma deal to develop OncoACP3, a novel prostate cancer therapy targeting ACP3, offering a potential alternative to PSMA-focused treatments.
Klotho Neurosciences Extends Lifespan by 20%, Stock Soars 788% w Klotho Neurosciences Klotho Neurosciences announces a breakthrough in anti-aging research, extending lifespan by 20% in mice using AAV-Klotho gene therapy. Stock price surges 788% on the news.
Radioligand Therapy in Oncology: Latest Advances in Targeted Radiopharmaceuticals from Nature Report Biotech Explore the latest Nature report on radioligand therapy (RLT) in oncology. Learn about innovations in isotopes, targeting ligands, and clinical pipelines driving the next wave of targeted radiopharmaceuticals.
Why Can Our Liver Regenerate? Key Gene Mechanisms in Liver Regeneration | Latest Cell Genomics Research Biotech Discover how the liver regenerates through key gene regulatory mechanisms revealed by latest research in Cell Genomics. Learn about enhancers and transcription factors driving liver regeneration.

<Pre12 3 Next >

Articles Archives

Hot Articles

All Categories

Agri & Industry Cosmetic Laboratory Pharmaceutical Food

国产91视频久久,亚洲综合色图在线观看,五月天操逼网,日韩色色AV,青青在线A片,亚洲最大色在线观看,欧美熟妇丝袜诱惑,青青操逼视频,日韩无码操出水